The importance of managing the clinical trial process cannot be overstated. With budgets in the hundreds of millions of dollars, time frames measured in decades and the cost and complexity of trials increasing, pharmaceutical firms know the critical importance of managing plan accuracy and timeliness and making better resource allocation decisions.
Overcome the limitations of transaction-based systems
Understanding and predicting the exact performance of a large phase 3 trial can be challenging. Forecasting with transaction-based CTMS typically follows the accrual method, with all its limitations:
Implement a proactive, activity-based approach
The IBM Cognos Clinical Trial Forecasting Performance Blueprint is designed to help financial professionals and clinical trial managers better forecast, plan and manage trial expenditures. It is an activity-based approach that matches expenses to activities:
Learn more about the IBM Cognos Clinical Trial Forecasting Performance Blueprint.